• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠肿瘤内微生物群落的异质性及其与结直肠癌发生的关系。

Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.

机构信息

Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Shenzhen Research Institute, Sha Tin, New Territories, Hong Kong.

Institute for Microbial Ecology, School of Medicine, Xiamen University, Department of Gastroenterology, Zhongshan Hospital, Xiamen University, Xiamen, China.

出版信息

Gastroenterology. 2021 Jun;160(7):2395-2408. doi: 10.1053/j.gastro.2021.02.020. Epub 2021 Feb 11.

DOI:10.1053/j.gastro.2021.02.020
PMID:33581124
Abstract

BACKGROUND & AIMS: Gut microbial dysbiosis has pivotal involvement in colorectal cancer (CRC). However, the intratumoral microbiota and its association with CRC progression remain elusive. We aimed to determine the microbial community architecture within a neoplasia (CRC or adenoma) and its contribution to colorectal carcinogenesis.

METHODS

We collected 436 tissue biopsies from patients with CRC (n = 36) or adenoma (n = 32) (2-6 biopsies from a neoplasia plus 2-5 biopsies from adjacent normal tissues per individual). Microbial profiling was performed using 16S ribosomal RNA gene sequencing with subsequent investigation of microbiota diversities and heterogeneity. The correlation between microbial dysbiosis and host genetic alterations (KRAS mutation and microsatellite instability) in all neoplasia biopsies was also analyzed.

RESULTS

We discovered that intra-neoplasia microbial communities are heterogeneous. Abundances of some CRC-associated pathobionts (eg, Fusobacterium, Bacteroides, Parvimonas, and Prevotella) were found to be highly varied within a single neoplasia. Correlation of such heterogeneity with CRC development revealed alterations in microbial communities involving microbes with high intra-neoplasia variation in abundance. Moreover, we found that the intra-neoplasia variation in abundance of individual microbes changed along the adenoma-carcinoma sequence. We further determined that there was a significant difference in intra-neoplasia microbiota between biopsies with and without KRAS mutation (P < .001) or microsatellite instability (P < .001), and illustrated the association of intratumoral microbial heterogeneity with genetic alteration.

CONCLUSIONS

We demonstrated that intra-neoplasia microbiota is heterogeneous and correlated with colorectal carcinogenesis. Our findings provide new insights on the contribution of gut microbiota heterogeneity to CRC progression.

摘要

背景与目的

肠道微生物失调与结直肠癌(CRC)密切相关。然而,肿瘤内微生物群及其与 CRC 进展的关系仍不清楚。本研究旨在确定肿瘤内微生物群落结构及其在结直肠癌变中的作用。

方法

我们收集了 36 例 CRC 患者和 32 例腺瘤患者的 436 份组织活检样本(每位患者从肿瘤中采集 2-6 份活检样本,从相邻正常组织中采集 2-5 份活检样本)。采用 16S 核糖体 RNA 基因测序进行微生物谱分析,随后研究微生物多样性和异质性。还分析了所有肿瘤活检样本中微生物失调与宿主遗传改变(KRAS 突变和微卫星不稳定性)之间的相关性。

结果

我们发现肿瘤内微生物群落存在异质性。某些与 CRC 相关的病原体(如梭菌、拟杆菌、小帕氏菌和普雷沃氏菌)在单个肿瘤内的丰度存在很大差异。这种异质性与 CRC 发展的相关性表明,微生物群落的改变涉及到丰度具有高肿瘤内变异性的微生物。此外,我们发现单个微生物在肿瘤内的丰度变化沿着腺瘤-癌序列发生改变。我们进一步确定,KRAS 突变(P <.001)或微卫星不稳定(P <.001)的活检样本之间,以及无 KRAS 突变或微卫星不稳定的活检样本之间,肿瘤内微生物群存在显著差异,并且说明了肿瘤内微生物异质性与遗传改变之间的关联。

结论

我们证明了肿瘤内微生物群是异质的,并与结直肠癌变相关。我们的研究结果为肠道微生物群异质性对 CRC 进展的贡献提供了新的见解。

相似文献

1
Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.结直肠肿瘤内微生物群落的异质性及其与结直肠癌发生的关系。
Gastroenterology. 2021 Jun;160(7):2395-2408. doi: 10.1053/j.gastro.2021.02.020. Epub 2021 Feb 11.
2
Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.1,2-二甲基肼诱导的“腺瘤-癌序列”小鼠结直肠癌模型中肠道微生物群的进化生物学变化
Oncotarget. 2017 Jan 3;8(1):444-457. doi: 10.18632/oncotarget.13443.
3
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.结直肠腺瘤患者粪便代谢组学特征与肠道微生物群及结直肠癌发病早期事件相关。
mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19.
4
Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.结直肠肿瘤发生过程中肠道微生物群和血浆炎症因子的变化:一项病例对照研究。
BMC Microbiol. 2018 Aug 29;18(1):92. doi: 10.1186/s12866-018-1232-6.
5
Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysis.基于 16S rRNA 基因测序的结直肠腺瘤-癌序列中肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Oct;195:106889. doi: 10.1016/j.micpath.2024.106889. Epub 2024 Aug 26.
6
Serrated neoplasia in the colorectum: gut microbiota and molecular pathways.结直肠锯齿状肿瘤:肠道微生物群和分子途径。
Gut Microbes. 2021 Jan-Dec;13(1):1-12. doi: 10.1080/19490976.2020.1863135.
7
Mucosa-associated microbiota signature in colorectal cancer.结直肠癌黏膜相关菌群特征。
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2073-2083. doi: 10.1007/s10096-017-3026-4. Epub 2017 Jun 9.
8
Relationship between , inflammatory mediators and microRNAs in colorectal carcinogenesis.在结直肠癌发生过程中 、炎症介质和 microRNAs 之间的关系。
World J Gastroenterol. 2018 Dec 21;24(47):5351-5365. doi: 10.3748/wjg.v24.i47.5351.
9
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.肠道微生物失调特征与结直肠癌变序列相关,并能提高结直肠病变的诊断效能。
J Gastroenterol Hepatol. 2020 Dec;35(12):2109-2121. doi: 10.1111/jgh.15077. Epub 2020 Jun 22.
10
Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.鉴定结直肠癌中 KRAS 突变相关的肠道微生物群,并构建预测性机器学习模型。
Microbiol Spectr. 2024 May 2;12(5):e0272023. doi: 10.1128/spectrum.02720-23. Epub 2024 Apr 4.

引用本文的文献

1
RESEARCH CHALLENGES IN STAGE III AND IV RAS-ASSOCIATED CANCERS: A Narrative Review of the Complexities and Functions of the Family of Genes and Ras Proteins in Housekeeping and Tumorigenesis.III期和IV期RAS相关癌症的研究挑战:关于管家基因和肿瘤发生过程中基因家族及Ras蛋白的复杂性与功能的叙述性综述
Biology (Basel). 2025 Jul 25;14(8):936. doi: 10.3390/biology14080936.
2
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials.基于纳米材料的癌症治疗中靶向肿瘤微生物群
Exploration (Beijing). 2025 Mar 24;5(4):e20210185. doi: 10.1002/EXP.20210185. eCollection 2025 Aug.
3
The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy.
肿瘤内微生物群在结直肠癌免疫治疗中的作用与挑战
Front Pharmacol. 2025 Aug 7;16:1634703. doi: 10.3389/fphar.2025.1634703. eCollection 2025.
4
Intratumoral microbial community profiling identifies clinicomolecular and prognostic subtypes of colorectal cancer liver metastasis.瘤内微生物群落分析可识别结直肠癌肝转移的临床分子和预后亚型。
NPJ Precis Oncol. 2025 Aug 15;9(1):284. doi: 10.1038/s41698-025-01075-5.
5
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy.利用肿瘤内微生物群:免疫微环境与免疫治疗的新视野
J Transl Med. 2025 Aug 12;23(1):897. doi: 10.1186/s12967-025-06916-2.
6
Advancements in understanding tumor-resident bacteria and their application in cancer therapy.肿瘤驻留细菌的认识进展及其在癌症治疗中的应用。
Mil Med Res. 2025 Jul 25;12(1):38. doi: 10.1186/s40779-025-00623-1.
7
The tumor microbiome in cancer progression: mechanisms and therapeutic potential.癌症进展中的肿瘤微生物群:机制与治疗潜力
Mol Cancer. 2025 Jul 15;24(1):195. doi: 10.1186/s12943-025-02403-w.
8
The intratumor microbiota and thyroid cancer: a review.肿瘤内微生物群与甲状腺癌:综述
Front Endocrinol (Lausanne). 2025 Jun 30;16:1536155. doi: 10.3389/fendo.2025.1536155. eCollection 2025.
9
Comparative microbiome analysis of paired mucosal and fecal samples in Korean colorectal cancer patients.韩国结直肠癌患者配对黏膜和粪便样本的微生物组比较分析。
Front Oncol. 2025 Jun 18;15:1578861. doi: 10.3389/fonc.2025.1578861. eCollection 2025.
10
Mechanistic Foundations of KRAS-Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment.KRAS驱动的肿瘤生态系统的机制基础:整合免疫、代谢、微生物和基质微环境之间的相互作用
Adv Sci (Weinh). 2025 Jun 9:e02714. doi: 10.1002/advs.202502714.